JP6385533B2 - リパーゼ阻害剤および皮脂分解抑制用皮膚化粧料 - Google Patents
リパーゼ阻害剤および皮脂分解抑制用皮膚化粧料 Download PDFInfo
- Publication number
- JP6385533B2 JP6385533B2 JP2017141238A JP2017141238A JP6385533B2 JP 6385533 B2 JP6385533 B2 JP 6385533B2 JP 2017141238 A JP2017141238 A JP 2017141238A JP 2017141238 A JP2017141238 A JP 2017141238A JP 6385533 B2 JP6385533 B2 JP 6385533B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- lipase
- sennenboku
- fennel
- melon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002374 sebum Anatomy 0.000 title claims description 33
- 229940086609 Lipase inhibitor Drugs 0.000 title claims description 28
- 239000002537 cosmetic Substances 0.000 title claims description 25
- 230000002401 inhibitory effect Effects 0.000 title claims description 21
- 230000015556 catabolic process Effects 0.000 title claims description 10
- 238000006731 degradation reaction Methods 0.000 title claims description 10
- 239000000284 extract Substances 0.000 claims description 104
- 239000004480 active ingredient Substances 0.000 claims description 11
- 239000002798 polar solvent Substances 0.000 claims description 5
- 241000219112 Cucumis Species 0.000 description 33
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 33
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 33
- 239000000203 mixture Substances 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 30
- 238000000605 extraction Methods 0.000 description 26
- 239000004367 Lipase Substances 0.000 description 25
- 102000004882 Lipase Human genes 0.000 description 25
- 108090001060 Lipase Proteins 0.000 description 25
- 229940040461 lipase Drugs 0.000 description 25
- 235000019421 lipase Nutrition 0.000 description 25
- 229940072117 fennel extract Drugs 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 240000006927 Foeniculum vulgare Species 0.000 description 14
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 14
- 235000013399 edible fruits Nutrition 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 208000017520 skin disease Diseases 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- 208000001840 Dandruff Diseases 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 235000019626 lipase activity Nutrition 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- -1 aliphatic alcohols Chemical class 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229940127470 Lipase Inhibitors Drugs 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 244000289527 Cordyline terminalis Species 0.000 description 2
- 235000009091 Cordyline terminalis Nutrition 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000009842 Cucumis melo Nutrition 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 235000008730 Ficus carica Nutrition 0.000 description 2
- 244000025361 Ficus carica Species 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000001668 ameliorated effect Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 235000020221 chamomile extract Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 229940122858 Elastase inhibitor Drugs 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000883 anti-obesity agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940125710 antiobesity agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003602 elastase inhibitor Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本実施形態のリパーゼ阻害剤は、フェンネル、メロン、イチジクおよびセンネンボクからなる群より選択される1種または2種以上の植物からの抽出物(以下、それぞれ「フェンネル抽出物」、「メロン抽出物」、「イチジク抽出物」、および「センネンボク抽出物」ということがある。)を有効成分とするものである。
以上のようにして得られるフェンネル抽出物、メロン抽出物、イチジク抽出物、またはセンネンボク抽出物は、優れたリパーゼ阻害作用を有しているため、リパーゼ阻害剤の有効成分として用いることができる。本実施形態のリパーゼ阻害剤は、医薬品、医薬部外品、化粧品等の幅広い用途に使用することができる。
フェンネル抽出物、メロン抽出物、イチジク抽出物、またはセンネンボク抽出物は、優れたリパーゼ阻害作用を有しているため、皮脂の状態をコントロールする用途に用いられる皮膚化粧料(以下、「皮脂コントロール用皮膚化粧料」という。)に配合するのに好適である。本実施形態の皮脂コントロール用皮膚化粧料は、フェンネル抽出物、メロン抽出物、イチジク抽出物またはセンネンボク抽出物が有するリパーゼ阻害作用を通じて、皮膚において皮脂の分解を抑制することにより皮脂の状態をコントロールし、これによりニキビ、フケ、皮膚炎などの皮脂分解に起因する皮膚疾患を予防、治療または改善することができる。
フェンネル(奈良県産)の葉部の乾燥物20gに対し、50%BG(1,3ブチレングリコール,ハイシュガーケインBG,高級アルコール工業社製)4kgを混合し、7日間浸漬した。ADVANTEC定性濾紙(No.2,東洋濾紙社製)およびメンブラン(0.45μm)を用いて濾過し、濾液としてフェンネル葉部抽出物(固形分:0.12質量%)を得た。
摘果メロン(北海道産)の果実部の細断物400gを用いて実施例1と同様に抽出し、メロン果実部抽出物(固形分:0.26質量%)を得た。
摘果イチジク(島根産)の果実部の乾燥物20gを用いて実施例1と同様に抽出し、イチジク果実部抽出物(固形分:0.15質量%)を得た。
アオヒロバセンネンボク(東京都小笠原諸島産)の葉部の乾燥物20gを用いて実施例1と同様に抽出し、センネンボク葉部抽出物(固形分:0.22質量%)を得た。
宍喰寒茶(徳島県産)の葉部の乾燥物20gを用いて実施例1と同様に抽出し、チャ葉部抽出物(固形分:0.12質量%)を得た。
上述のようにして得られたフェンネル抽出物(実施例1)、メロン抽出物(実施例2)、イチジク抽出物(実施例3)、センネンボク抽出物(実施例4)およびチャ抽出物(比較例1)について、以下のようにしてリパーゼ活性を測定した。
下記組成に従い、乳液を常法により製造した。
フェンネル抽出物(実施例1) 0.01g
ホホバオイル 4.00g
1,3−ブチレングリコール 3.00g
アルブチン 3.00g
ポリオキシエチレンセチルエーテル(20E.O.) 2.50g
オリーブオイル 2.00g
スクワラン 2.00g
セタノール 2.00g
モノステアリン酸グリセリル 2.00g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 2.00g
パラオキシ安息香酸メチル 0.15g
グリチルリチン酸ステアリル 0.10g
黄杞エキス 0.10g
グリチルリチン酸ジカリウム 0.10g
イチョウ葉エキス 0.10g
コンキオリン 0.10g
オウバクエキス 0.10g
カミツレエキス 0.10g
香料 0.05g
精製水 残部(全量を100gとする)
下記組成のクリームを常法により製造した。
メロン抽出物(実施例2) 0.05g
クジンエキス 0.1g
オウゴンエキス 0.1g
流動パラフィン 5.0g
サラシミツロウ 4.0g
スクワラン 10.0g
セタノール 3.0g
ラノリン 2.0g
ステアリン酸 1.0g
オレイン酸ポリオキシエチレンソルビタン(20E.O.) 1.5g
モノステアリン酸グリセリル 3.0g
油溶性甘草エキス 0.1g
1,3−ブチレングリコール 6.0g
パラオキシ安息香酸メチル 1.5g
香料 0.1g
精製水 残部(全量を100gとする)
下記組成の美容液を常法により製造した。
イチジク抽出物(実施例3) 0.01g
センネンボク抽出物(実施例4) 0.01g
カミツレエキス 0.1g
ニンジンエキス 0.1g
キサンタンガム 0.3g
ヒドロキシエチルセルロース 0.1g
カルボキシビニルポリマー 0.1g
1,3−ブチレングリコール 4.0g
グリチルリチン酸ジカリウム 0.1g
グリセリン 2.0g
水酸化カリウム 0.25g
香料 0.01g
防腐剤(パラオキシ安息香酸メチル) 0.15g
エタノール 2.0g
精製水 残部(全量を100gとする)
Claims (2)
- センネンボクの葉部を極性溶媒で抽出して得られる抽出物を有効成分とすることを特徴とするリパーゼ阻害剤。
- センネンボクの葉部を極性溶媒で抽出して得られる抽出物を配合したことを特徴とする皮脂分解抑制用皮膚化粧料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017141238A JP6385533B2 (ja) | 2017-07-20 | 2017-07-20 | リパーゼ阻害剤および皮脂分解抑制用皮膚化粧料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017141238A JP6385533B2 (ja) | 2017-07-20 | 2017-07-20 | リパーゼ阻害剤および皮脂分解抑制用皮膚化粧料 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013225971A Division JP2015086168A (ja) | 2013-10-30 | 2013-10-30 | リパーゼ阻害剤および皮脂コントロール用皮膚化粧料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017203032A JP2017203032A (ja) | 2017-11-16 |
JP6385533B2 true JP6385533B2 (ja) | 2018-09-05 |
Family
ID=60321965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017141238A Active JP6385533B2 (ja) | 2017-07-20 | 2017-07-20 | リパーゼ阻害剤および皮脂分解抑制用皮膚化粧料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6385533B2 (ja) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005008572A (ja) * | 2003-06-19 | 2005-01-13 | Yakult Honsha Co Ltd | リパーゼ阻害剤 |
JP4644787B2 (ja) * | 2003-08-19 | 2011-03-02 | 沖縄県 | リパーゼ阻害活性且つ抗酸化性を有する抗肥満剤 |
JP4199743B2 (ja) * | 2005-03-03 | 2008-12-17 | 株式会社ディーエイチシー | ニキビ用皮膚化粧料 |
DE102005012832A1 (de) * | 2005-03-17 | 2006-09-28 | Schrezenmeier, Jürgen, Prof. Dr. | Arzneimittel aus Pflanzenextrakten als Lipaseinhibitor |
JP2010209051A (ja) * | 2009-03-12 | 2010-09-24 | Morishita Jintan Co Ltd | 脂肪吸収抑制剤 |
-
2017
- 2017-07-20 JP JP2017141238A patent/JP6385533B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017203032A (ja) | 2017-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6054700B2 (ja) | 脱糖化剤及び皮膚外用剤 | |
JP5137457B2 (ja) | 幹細胞増殖因子発現上昇抑制剤 | |
JP5041569B2 (ja) | チロシナーゼ活性阻害剤、美白剤及び皮膚化粧料 | |
JP6138317B2 (ja) | 皮膚外用剤 | |
Garg et al. | Exploring the potential of Moringa oleifera Lam in skin disorders and cosmetics: nutritional analysis, phytochemistry, geographical distribution, ethnomedicinal uses, dermatological studies and cosmetic formulations | |
JP2015086168A (ja) | リパーゼ阻害剤および皮脂コントロール用皮膚化粧料 | |
JP2014221739A (ja) | Vii型コラーゲン発現促進剤 | |
JP2012162487A (ja) | 美白剤、抗老化剤及び皮膚化粧料 | |
JP6385533B2 (ja) | リパーゼ阻害剤および皮脂分解抑制用皮膚化粧料 | |
JP2011001326A (ja) | エンドセリン−1mRNA発現抑制剤 | |
KR101617730B1 (ko) | 인삼열매, 포도씨 추출물을 포함하는 화장료 조성물 및 이를 이용한 화장품 | |
JP5896618B2 (ja) | メラニン産生抑制剤 | |
JP6723979B2 (ja) | しわ改善剤 | |
KR20170058546A (ko) | 주름개선용 화장료 조성물 | |
KR102585725B1 (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
JP6017259B2 (ja) | エンドセリン作用抑制剤 | |
KR102480364B1 (ko) | 피부 상태 개선용 화장료 조성물 및 이의 제조방법 | |
JP5993724B2 (ja) | エラスチン産生促進剤及び皮膚化粧料 | |
JP6267412B2 (ja) | cAMP産生抑制剤 | |
JP7402478B2 (ja) | 神経成長因子発現抑制剤およびセマフォリン3a発現促進剤 | |
JP2010215535A (ja) | メラニン産生抑制剤 | |
JP2019055924A (ja) | Endo180産生促進剤 | |
JP2008074777A (ja) | メラノサイト活性化抑制剤、及び皮膚外用剤 | |
JP2024073704A (ja) | ヘパリン結合性上皮成長因子様増殖因子 mRNA発現促進剤 | |
Madu et al. | EXTRACTION, STABILIZATION AND GC-MS CHARACTERIZATION OF ETHANOLIC LEAF EXTRACTS OF ALOE VERA GEL AND RIND |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180522 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180608 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180713 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180731 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180807 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6385533 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |